NCI - phip-SEQ huscan service

Active Purchase Order Awarded Last action

Contract number
75N98026P01078
Awardee
Awarding agency
Obligated
$49,400

Award facts

Contract value 100% obligated
$49,400.00 Current and potential, with all options
Completion date 26% complete
Current and potential, with all options
Funding agency
National Cancer Institute National Institutes of Health, Department of Health and Human Services
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Mayagüez, Puerto Rico

Award details come from SAM.gov/FPDS.

About this award

The National Cancer Institute awarded a purchase order to CDI Laboratories Inc. for $49,400.00 on July 27, 2026, for NCI PhIP-Seq HuScan service. CDI Laboratories is a small disadvantaged business manufacturer based in Mayagüez, Puerto Rico. Work is performed in Mayagüez, Puerto Rico. The order is firm fixed price with no set-aside category applied. Performance is due by July 26, 2027.

Quick answers

Who was awarded contract 75N98026P01078?

75N98026P01078 was awarded to CDI Laboratories Inc. by Office of Logisitics and Acquisition Operations (National Institutes of Health) on July 27, 2026.

How much is contract 75N98026P01078 worth?

The government has obligated $49,400 on 75N98026P01078.

Which agency awarded contract 75N98026P01078?

Office of Logisitics and Acquisition Operations (National Institutes of Health) awarded 75N98026P01078, with funding from National Cancer Institute (National Institutes of Health).

Was contract 75N98026P01078 competed?

The extent of competition for 75N98026P01078 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award